Organized by:
ISD_Mainidentifier_RGB_transparent.fw.pn
MOTAC_Logo_Jata - EN.PNG
MSIDC logo transparent.fw.png
Supported by:
myceb_logo_180mm_FC_RGB.jpg
ISID Logo

9 Babcock Street, Unit 3

Brookline, MA 02446

United States

info@isid.org

Tel: +1 (617) 277-0551

Fax: +1 (617) 278-9113

  • White Facebook Icon
  • White Twitter Icon

© 2019 International Society for Infectious Diseases

SCIENTIFIC PROGRAM

*Scientific Program is subject to change due to postponement and will be updated as more information is available. 

Friday, September 11, 2020 

 

MEET THE EXPERT

 

Urinary Tract Infections – Updates in Prevention and Management

Room: HS 6M / Mezzanine

Friday, September 11, 2020, 08:00 – 09:00 hrs

  


  • S. Roberts (New Zealand)

  • T. Chow (Malaysia)

 

Meet the Editors 

Room: HS 7M / Mezzanine

Friday, September 11, 2020, 08:00 – 09:00 hrs

(In collaboration with Elsevier)


Co-chairs: J. McConnell (UK), R. Sarkar (UK)
 

  • International Journal of Infectious Diseases – E. Petersen (Denmark)

  • International Journal of Infectious Diseases – S. McLellan (USA)

  • International Journal of Infectious Diseases – I. Praharaj (India)

  • The Lancet Digital Health – R. Sarkar (UK)

  • The Lancet Infectious Diseases – J. McConnell (UK)

  • Infectious Disease Cases – L. Lutwick (USA)

The Future of Rotavirus Vaccines: Novel Approaches to Increase Impact

Room: HS 8M / Mezzanine

Friday, September 11, 2020, 08:00 – 09:00 hrs

(in collaboration with the Rotavirus Organization of Technical Allies, International Vaccine Access Center)

  


  • M. Santosham (USA)

  • C. Kirkwood (USA)

 

PLENARY

 

Plenary I
At the Forefront of Hepatitis C Virus Elimination

Room: EH 7 C / Level 3

Friday, September 11, 2020, 09:15 – 10:00 hrs

Chair: R. Hajjeh (Egypt)

  • Malaysia’s Hepatitis C Elimination Journey – Global Impact and opportunity – Datuk Dr. Noor Hisham Abdullah (Malaysia)

  • Egypt's Experience in the Elimination of Hepatitis C – W. Doss (Egypt)

 

PARALLEL SYMPOSIA


 

Serosurveillance for Spillover of High Consequence Zoonotic Viruses at the Human-Animal Interface

Room: EH 8B / Level 4

Friday, September 11, 2020, 10:30 – 12:00 hrs

(In collaboration with EcoHealth Alliance)

Co-chairs: J. Epstein (USA), A. Hilmers (USA)

 

  • TBD - C. Broder (Singapore)

  • Bat Antibody Dynamics in Time: What Can We Learn about Pathogen Dynamics from Multiplexed Luminex Serological Assays – S. Seifert (Canada)

  • Serological Biosurveillance for Spillover of Henipaviruses and Filoviruses at Agricultural and Hunting Human-Animal Interfaces in Peninsular Malaysia – M.H. Lee (Malaysia)

Clinical Management of Hard to Treat Infections

Room: EH 7B / Level 3

Friday, September 11, 2020, 10:30 – 12:00 hrs

(In collaboration with the Malaysian Society of Infectious Diseases and Chemotherapy)

Co-chairs: Z. Sekawi (Malaysia), D. Lye (Singapore)

 

  • Management of Persistent MRSA Infections – P. Tambyah (Singapore)

  • Optimizing Management of Polymyxin Resistant Enterobacteriaceae – TBD

  • Treatment Options and the Role of PK/PD in Dose Optimization of Carbapenem-Resistant Acinetobacter baumannii – S. M. S Lim (Australia)

 

Infectious Disease Innovations for a Digital World

Room: EH 8A / Level 4

Friday, September 11, 2020, 10:30 – 12:00 hrs

(In collaboration with Lancet ID and Lancet Digital Health)

Co-chairs: J. McConnell (UK), R. Sarkar (UK)
 

  • The Use of Mobile Phone Data for Outbreak Tracking – A. Wesolowski (USA)

  • Towards Data-Driven Decision-Making in Malaria: Digital and Genomic Tools – TBD

  • A look into the Future - Using Digital Disease Surveillance Tools for Near Real-time Epidemic Forecasting – S. Bhatia (UK)
     

Oral Abstracts - Antimicrobial Use and Stewardship

Room: HS 6M / Mezzanine

Friday, September 11, 2020, 10:30 – 12:00 hrs

Co-chairs: A. Shibl (Saudi Arabia), E. Charani (UK)

  • Global antibiotic consumption: a modelling study - A. Browne (UNITED KINGDOM)

  • Current antimicrobial stewardship programmes in public sector facilities across South Africa: Has the National AMR Strategy Framework made an impact? - D. Engler (SOUTH AFRICA)

  • Investigating team dynamics and communication in surgical teams in relation to antibiotic prescribing and infection control - C. Bonaconsa (SOUTH AFRICA)

  • Recurrence of Clostridioides difficile infection: a multicenter study on incidence and risk factors - N. Petrosillo (ITALY)

  • Investigation of community-associated Clostridium (Clostridioides) difficile infections in the Asia-Pacific region, D. Collins (AUSTRALIA)

  • Antimicrobial use in two-week recall of febrile illness: A descriptive study based on Healthcare Utilization Survey in India - S. Thomas (INDIA)

  • Practice of over-the-counter dispensary of antibiotics for childhood illnesses in Addis Ababa, Ethiopia: a simulated patient encounter study - Tinsae Alemayehu (ETHIOPIA)

  • Antimicrobial prescribing trends and appropriateness in a tertiary teaching hospital in Malaysia - Ly Sia Loong (MALAYSIA)

 

The Global Rise of Sexually Transmitted Infections

Room: HS 7M / Mezzanine

Friday, September 11, 2020, 10:30 – 12:00 hrs

(In collaboration with GARDP)

Co-chairs: C. Ferreyra (Switzerland), TBD

  • Public Health Driven Development of New Treatments for Multi-drug Resistant Gonorrhea – S. O'Brien (Switzerland)

  • Resurgence of Syphilis – TBD

  • Network Approach to Tracking the Dissemination of Sexually Transmitted Infections in the Community – S. S. Lee (Hong Kong)

 

WORKSHOP

 

The Guide to Infection Control in the Healthcare Setting

Friday, September 11, 2020, 12:30 – 13:45 hrs, Room: HS 6M / Mezzanine

 

G. Bearman (USA); M. Doll (USA); A. Desai (USA)

  • 12:30 to 12:45: Guide to Infection Control in the Healthcare Setting – Introduction and background

  • 12:45 to 12:50: International Society for Infectious Diseases - Position Papers - Implementing infection prevention and control measures across different resource settings

  • 12:50 to 13:25: We Need YOU – How to Get Involved

  • 13:25 to 13:45: What Can We Do to Make the Guide Better – Feedback Session

This workshop is open to registered Congress attendees at no additional cost. No pre-registration is necessary.

 

PARALLEL SYMPOSIA

Leadership Skills Development

Room: EH 8B / Level 4

Friday, September 11, 2020, 14:00 – 15:30 hrs
 

  • Presenting your Work: Storytelling Skills and Techniques to Make You a Great Presenter – K. Rebmann (USA)

Global Action on Antimicrobial Resistance - New Control and Treatment Strategies

Room: EH 7B / Level 3

Friday September 11, 2020, 14:00 – 15:30 hrs

(In collaboration with the Japanese Association for Infectious Diseases)

Co-chairs: K. Yanagihara (Japan), S. Amin Nordin (Malaysia)

 

  • International Comparison of Antibiotic-resistant Bacteria in Urinary Tract Infection – K. Shigemura (Japan)

  • Enhancing the International Coordination of Antimicrobial Resistance Research and Development – E. Nimmesgern (Germany)

  • Adjunctives and Alternatives to Antibiotics - Phages, Microbiome-modulating, Immune Approaches and Others – U. Theuretzbacher (Austria)

 

Vaccines to Prevent Respiratory Disease Morbidity and Mortality 


Room: EH 8A / Level 4

Friday, September 11, 2020, 14:00 – 15:30 hrs

(In collaboration with the Bill & Melinda Gates Foundation)

Co-chairs: TBD, TBD

 

  • Vaccines to Prevent Respiratory Disease Morbidity and Mortality – F. Russell (Australia)

  • Introduction of and Access to PCV Vaccination in LMICs – B. Hausdorff (USA)

  • Lessons Learned from the Genomic Surveillance of Streptococcus pneumoniae – S. Lo (UK)

 

Oral Abstracts - Emerging, Re-Emerging, and Zoonotic Infections

Room: EH 6M / Mezzanine

Friday, September 11, 2020, 14:00 – 15:30 hrs

Co-chairs: B. Maiga (Mali), M. Pollack (USA)

  • In search for the hotspots of Disease X: A biogeographic approach to mapping the predictive risk of WHO’s Blueprint Priority Diseases - S. Jagadesh, (FRANCE)

  • What is the Best Way to Diagnose Dengue Haemorrhagic Fever Early? Routine Application of Ultrasound for Early Detection of Dengue Haemorrhagic Fever - L. Fernando (SRI LANKA)

  • Descriptive epidemiology of monkeypox in Nigeria, September 2017 - June 2019 - S. Akar (NIGERIA)

  • Exploring the burden of Ntwetwe virus – a novel orthobunyavirus associated with CNS infections – in Ugandan children - N. van den Brekel, (NETHERLANDS)

  • Circulation of Nipah virus at the human-Flying fox interface in Cambodia - V. Duong (CAMBODIA)

  • Molecular characterization of Acanthamoeba isolated from contact lens paraphernalia: An evidence of potentially pathogenic T4 genotype in Malaysia - R.H. Mohd Hussain (MALAYSIA)

  • Puumala orthohantavirus genome sequence variations in the Republic of Tatarstan, Russia, - E. Kabwe (RUSSIAN FEDERATION)

Enterovirus Infections in Asia Pacific – Critical Updates 

Room: HS 7 M / Mezzanine

Friday, September 11, 2020, 14:00 – 15:30 hrs

Co-chairs: K. K. Wong (Malaysia), R. Heyderman (UK)
 

  • Asia-Pacific Network for Enterovirus Surveillance Overview and Development of Enterovirus A71 Vaccines – M. Lee (Taiwan)

  • Laboratory Diagnosis and Management of Enterovirus Infections – Y. F. Chan (Malaysia)

  • Genetic and Antigenic Evolution of Enteroviruses in Asia Pacific – J. Phuenpa (Thailand)

 

PLENARY

 

Plenary II

Emerging Infectious Diseases Preparedness – Looking Through the One Health Lens


Room: EH 7C /Level 3

Friday, September 11, 2020, 16:00 – 17:00 hrs

Chair: J. Cohen (UK)

  • Pandemic Preparedness in China – G. Gao (China)

  • Climate Change, Migration and Infectious Diseases – K. Kumari Rigaud (USA)

  • Environmental Change and Emerging Infectious Diseases – P. Daszak (USA)

 

 

Saturday, September 12, 2020 

 

MEET THE EXPERT


 

Surgical Site Infections – Updates in Prevention and Management


Room: HS 6M / Mezzanine

Saturday, September 12, 2020, 08:00 - 09:00 hrs

 

  • A. Holmes (UK), S. S. L. S. Ponnampalavanar (Malaysia)

 

Travel Medicine Updates


Room: HS 8M / Mezzanine

Saturday, September 12, 2020, 08:00 - 09:00 hrs

(in collaboration with the International Society of Travel Medicine)

 

  • L. H. Chen (USA), C. Coyle (USA)

 

PLENARY

 

Plenary III

Room: EH 7 C / Level 3

Saturday, September 12, 2020, 09:15 - 10:00 hrs

Chair: M. Mendelson (South Africa)

  • Collaborating with the Innate Immune System to Control Antibiotic-Resistant Superbugs – V. Nizet (USA)

 

PARALLEL SYMPOSIA


 

Malaysia’s Hepatitis C Elimination Journey – Global Implications and Opportunities

Room: EH 8B / Level 4

Saturday, September 12, 2020, 10:30 – 12:00 hrs

(In collaboration with DNDi and FIND)

Chair: Datuk Dr Noor Hisham Abdullah (Malaysia)
 

  • Malaysia’s Hepatitis C Elimination Journey – Global Implications and Opportunities – Datuk Dr. Muhammad Radzi Abu Hassan (Malaysia)

  • Equitable and Sustainable Access to HCV Treatment – F. Bompart (Switzerland)

  • Innovation and Integration of HCV Diagnostics to Facilitate Linkage to Care –S. Shilton (Switzerland)

  • Options for Use of Government's Rights in Malaysia's Patents Act – Y. L Chee  (Malaysia) 

Clinical Management of Multidrug Resistant Infections 

Room: EH 7 B / Level 3

Saturday, September 12, 2020, 10:30 – 12:00 hrs

(In collaboration with ESCMID)

Co-chairs: N. Petrosillo  (Italy), A. Adnan (Malaysia)

 

  • New Directions in the Management of Resistant GNRs – N. Petrosillo (Italy)

  • Gram-positive Cocci Resistance - Clinical Management – S. Kumar (Malaysia)

  • Drug Resistant Enteric Pathogens (including S. typhi) – P. Rupali (India)

 

Pandemic Preparedness – 25 Years of ProMED

Room: EH 8A / Level 4

Saturday, September 12, 2020, 10:30 – 12:00 hrs

(In collaboration with ProMED)

Co-chairs: L. Madoff (USA), L. MacKinnon (USA), M. Pollack (USA)

 

  • Declaration of Public Health Emergencies of International Concern (PHEIC) – Whether, When, and Why – R. Steffen (Switzerland)

  • Climate and Global Disease Outbreaks: The View from 36,000km – A. Anyamba (USA)

  • Innovative use of ProMED Data for Epidemiologic Insights – A. Desai (USA)

 

Oral Abstracts - Viral Infections

Room: HS 6M / Mezzanine

Saturday, September 12, 2020, 10:30 – 12:00 hrs
Co-chairs: G. Screaton (UK), A. Scagliarini (Italy)

  • A sentinel surveillance system for viral respiratory infections in children attending child care centres in Singapore - M. Zahari (SINGAPORE)

  • Antiviral prophylaxis is effective in reducing influenza outbreak severity in residential care - S. Fletcher-Lartey (AUSTRALIA)

  • Detection and genetic characterization of avian influenza A (H5N6) virus clade 2.3.4.4 in isolates from house crow and poultry in Bangladesh, 2017 -
    A. Islam (BANGLADESH)

  • The interaction between hepatitis C infection and risk of cardiovascular disease in Canadians: A Bayesian network modeling study - A. Badawi (CANADA)

  • Clinically relevant markers of infection revealed through population genetics: the example of cytomegalovirus infections - T. Kowalik (USA)

  • Enterovirus and Gut Virome Profile in Indian Infants and Immune Response to Oral Rotavirus Vaccine - I. Praharaj (INDIA)

  • Effect of systemic corticosteroid use on risk of herpes zoster in a population-based cohort study - J.Qian (AUSTRALIA)

 

HIV – Hot Topics 

Room: HS 7M / Mezzanine

Saturday, September 12, 2020, 10:30 – 12:00 hrs

(In collaboration with the International AIDS Society)

Co-chairs: A. Kamarulzaman (Malaysia), W. Powderly (USA)
 

  • HIV Pre-Exposure Prophylaxis (PrEP) Updates for the Infectious Disease Physician – I. Azwa (Malaysia)

  • Same Day ART Initiation – TBD

  • Treatment of Latent TB Infection – S. Wasserman (South Africa)

 

WORKSHOP


 

ICID/ProMED Feedback Session: Epidemic Preparedness

Room: HS 7M / Mezzanine

Saturday, September 12, 2020, 12:30 – 13:45 hrs
 

TBD

This workshop is open to registered Congress attendees at no additional cost. No pre-registration is necessary.

Bring Your Manuscript 

Room: HS 6M / Mezzanine

Saturday, September 12, 2020, 12:30 – 13:45 hrs

 

  • E. Petersen (Denmark), Editor-in-Chief, International Journal of Infectious Diseases

  • J. McConnell (UK), The Lancet Infectious Diseases

  • R. Sarkar (UK), The Lancet Digital Health

  • L. Lutwick (USA), IDCases

  • S. McLellan (USA), Editor, International Journal of Infectious Diseases

  • S. Wasserman (South Africa), Assistant Editor, International Journal of Infectious Diseases

  • I. Praharaj (India), Assistant Editor, International Journal of Infectious Diseases
     

This workshop is open to registered Congress attendees at no additional cost. Click here to register.

PARALLEL SYMPOSIA


 

Leadership Skills Development:

Managerial Decision Making: Pitfalls and Remedies

Room: EH 7A / Level 3

Saturday, September 12, 2020, 14:00 – 15:30 hrs

Co-chairs: S. Wasserman (South Africa), A. Amir (Pakistan)

  • Managerial Decision Making: Pitfalls and Remedies – F. de Véricourt (Germany)

Panel Discussion: Antimicrobials - Access and Stewardship: How Do We Get the Balance Right?

Room: EH 7B / Level 3

Saturday, September 12, 2020, 14:00 – 15:30 hrs

(in collaboration with DNDi and GARDP)

Moderators: A. Holmes (UK), E. Charani (UK)

 ​

  • What are the Key Components of Access and Stewardship – TBD

  • How to Manage Access and Stewardship in Antibiotic R&D?  – S. O’Brien (Switzerland)

  • Should we Introduce Mass Drug Administration of Azithromycin to reduce child mortality? – M. Mendelson (South Africa)

  • How to introduce new antimicrobials for Multidrug Resistant Pathogens in High-endemic Settings – P. Sirivongrangson (Thailand)

 

Debate: Antibiotics for Diarrheal Disease

Room: EH 8B / Level 4

Saturday, September 12, 2020, 14:00 – 15:30 hrs

 

Debaters:

  • M. O’Ryan (Chile)

  • P. Ashorn (Finland)
     

Oral Abstracts - Preventing Infectious Diseases

Room: HS 6M / Mezzanine

Saturday, September 12, 2020, 14:00 – 15:30 hrs

Co-chairs: TBD, R. Aziz (Egypt)

  • Relative Vaccine Effectiveness of Adjuvanted Trivalent Influenza Vaccine compared to Egg-Based Trivalent High Dose and other Egg-Based Vaccines –

  • J. Mould (USA)

  • Influenza vaccine uptake and its effectiveness in preventing hospitalisations among Australian children with chronic lung diseases – N. Homaira (AUSTRALIA)

  • Five-year antibody persistence and boostability following PVRV ID post-exposure prophylaxis schedules in Filipinos exposed to suspected rabid animals – C. Ambas (PHILIPPINES)

  • A Sarawak Experience on the Use of IPC ID PEP Regimen In Patients Bitten By Laboratory Confirmed Rabies Animals – H.H. Chua (MALAYSIA)

  • MVA-BN as Monkeypox Vaccine for Healthy and Immunocompromised Adults – T. Meyer (GERMANY)

  • Generating data for typhoid conjugate vaccine introductions in Africa - Results from the Severe Typhoid Fever Surveillance in Africa Program (SETA) –
    F. Marks (UNITED KINGDOM)

  • The contribution of host genetics and environmental variation to immune response in gamma-herpesvirus infections – N. Sallah (UNITED KINGDOM)

  • Development & implementation of a customized infection control program in South African Correctional Centres – A. Duse (SOUTH AFRICA)

Rabies - Key Areas of Focus for Successful Elimination

Room: HS 7 M / Mezzanine

Saturday, September 12, 2020, 14:00 – 15:30 hrs

Co-chairs: C. Rupprecht (USA), P. Beldomenico (Argentina)

  • The Futility of Therapeutics and the Utility of Intradermal Immunization for Human Rabies Prophylaxis – A. Bastola (Nepal)

  • Mass Canine Vaccination: A Proven One Health Context for the Elimination of Human Rabies Caused by Dogs – U. R. Siddiqi (Bangladesh)

  • Do we Need Oral Bait Vaccination to Eliminate Dog Mediated Human Rabies? – G. Yale (India)

 

PLENARY

 

Plenary IV

Malaria

Room: EH 7C / Level 3

Saturday, September 12, 2020, 16:00 - 17:00 hrs

Chair: Z. Sekawi (Malaysia)

 

  • The Threat of Multidrug Resistant Falciparum Malaria – E. Ashley (Lao PDR)

  • Getting back on Track: the Tools and Strategies Needed to Achieve Malaria Elimination and Eradication – A. Ghani (UK)

  • Plasmodium knowlesi - Malaria at the One Health Interface – M.Y Fong (Malaysia)

Late Breaker Session: Panel Discussion: 2019-nCoV Outbreak

Room: EH 7A / Level 3
Saturday, September 12, 2020, 17:15 - 18:15 hrs

Moderator: L. Madoff (USA)

  • Nahoko Shindo (Switzerland)

  • Marjorie Pollack (USA)

  • Peter Daszak (USA)

  • Linfa Wang (Singapore)

  • John MacKenzie (Australia)

  • Hume Field (USA)

 

Sunday, September 13, 2020 

MEET THE EXPERT


 

 

A Career in Global Health and Public Health


Room: HS 6 M / Mezzanine

Sunday, September 13 , 2020, 08:00 - 09:00 hrs

 

  • R. Hajjeh (Egypt), W. N. W. Mohamed (Malaysia)
     

Management of Infective Endocarditis 


Room: HS 7M / Mezzanine

Sunday, September 13, 2020, 08:00 - 09:00 hrs

 

  • K. M. J. Chan (Malaysia), TBD

Early Childhood Diarrheal Disease: Causes, Consequences, and Control 


Room: HS 8M / Mezzanine

Sunday, September 13, 2020, 08:00 - 09:00 hrs

 (in collaboration with the Rotavirus Organization of Technical Allies, International Vaccine Access Center)

  • N. Wadwha (India)

  • S. S. R Ajjampur (India)

 

PLENARY

 

Plenary V

Room: EH 7A / Level 3

Sunday, September 13, 2020, 09:15 - 10:00 hrs

Chair: B. Lassmann (USA)

 

  • Using Novel Data Sources to Tackle the Next Outbreak – A. Wesolowski (USA)

 

PARALLEL SYMPOSIA


 

Utilizing Newer Diagnostic Tests 

Room: EH 7A / Level 3

Sunday, September 13, 2020, 10:30 – 12:00 hrs

Co-chairs: S. Roberts (New Zealand), N. Ahmad (Malaysia)
 

  • Translating Genomics into Practice – D. Williamson (Australia)

  • Utilization of POC Tests and Biomarkers in Infectious Diseases in LMICs – S. Blacksell (Thailand)

  • The Lab of the Future: Artificial Intelligence and Microfluids – J. R. Manzano (UK)

 

Developing Vaccine Confidence

Room: EH 7B / Level 3

Sunday, September 13, 2020, 10:30 – 12:00 hrs

Chair: A. Shet (USA)

  • Vaccine Hesitancy from a Low/Middle Income Country Perspective Including Resurgence of Measles in the Philippines and the Issues Around the Dengue Vaccine Rollout in the Philippines – L. Bravo (Philippines)

  • The Relationship Between Vaccine Mandates and Vaccine Confidence – K. Attwell (Australia)

  • Q/A Session – A. Shet (USA)

 

Oral Abstracts - Bacterial Infections and Antimicrobial Resistance

Room: HS 6M / Mezzanine

Sunday, September 13, 2020, 10:30 – 12:00 hrs

Co-chairs: C.L. Leong (Malaysia), P. Brown (Jamaica)

  • Addressing Antimicrobial resistance in China: progress and challenges in translating political commitment into national action – N. Zhu (UNITED KINGDOM)

  • Development of an algorithm to prevent neonatal Healthcare-Associated Infections (HAIs): A Multimodal approach – U. Rani (INDIA)

  • Rectal colonization with multidrug-resistant Gram-negative bacteria:  prevalence and risk factors among pregnant women in Cape Town, South Africa – A.N.H. Bulabula (SOUTH AFRICA)

  • Antimicrobial Resistance Profile of Streptococcus pneumoniae in Children <5 Years of Age in Sea Nomads Population in Indonesia – W.O.D. Daningrat (INDONESIA)

  • Stool shedding of Salmonella Typhi in children with blood culture-confirmed typhoid fever –M. Srinivasan (INDIA)

  • Genomic insights into multi-drug and extensively drug resistant Klebsiella pneumoniae from India –C. Shankar (INDIA)

  • Carbapenem non-susceptibility associated with global transcriptional regulator MarA in Escherichia coli – S. Chetri (INDIA)

  • Cerebrospinal fluid MinION sequencing of 16S rRNA gene for rapid and accurate diagnosis of bacterial meningitis – H. Nguyen (VIET NAM)

Current Updates in Tuberculosis

Room: HS 7M / Mezzanine

Sunday, September 13, 2020, 10:30 – 12:00 hrs

Co-chairs: T. Brewer (USA), Y. Suputtamongkol (Thailand)
 

  • Tuberculosis at the Host Pathogen Interface – C. Ong (Singapore)

  • MDR-TB Treatment Update – S. Wasserman (South Africa)

  • TB experimental therapeutics - a look into the future – G. Cook (New Zealand)

 

PARALLEL SYMPOSIA


 

Neglected Tropical and Zoonotic Diseases

Room: EH 7A / Level 3

Sunday, September 13, 2020, 14:00 – 15:30 hrs

Co-chairs: R. Colebunders (Belgium), C. Ukaga (Nigeria)

  • The Role of Animal Reservoir in Spreading Human Leptospirosis in Southeast Asia – Z. Sekawi (Malaysia)

  • Melioidosis: Australia’s Greatest Mystery Export? – TBD

  • Sarcocystis: From Snakes to Humans – K.T. Wong (Malaysia)

 

Hospital-Acquired Infections - How Much Can We Prevent?

Room: EH 7B / Level 3

Sunday, September 13, 2020, 14:00 – 15:30 hrs

Co-chairs: Z. Deris (Malaysia), M. Doll (USA)
 

  • HAIs - How Much Can We Prevent and How to Manage Expectations – G. Bearman (USA)

  • Screening Strategies in Different Resource Settings – N. Suwantarat (Thailand)

  • Candida auris – The Threat of Multidrug-resistant Nosocomial Fungi – L. Chai (Singapore)

 

Oral Abstracts - Hot Topics

Room: HS 6M / Mezzanine

Sunday, September 13, 2020, 14:00 – 15:30 hrs

Co-chairs: Y. Malik (Malaysia), A. Biswas (India)

  • Poverty and health among CDC plantation labourers in Cameroon: Perceptions, challenges and coping strategies – V.D. Makoge Epse Forbin (CAMEROON)

  • Development and evaluation of a mobile digital quiz game for the promotion of malaria awareness, positive perceptions and appropriate practices – U. Chukwuocha, (NIGERIA)

  • Cost-Effectiveness Analysis of PBO-LLINs compared to Non PBO LLINs in the reduction of Malaria among children in Jinja District – M. Kaakyo (UGANDA)

  • The utility of telephone helpline data for real-time syndromic surveillance of adverse events following immunization: Retrospective evaluation – Y. Mesfin (AUSTRALIA)

  • PEN-FAST: A validated penicillin allergy clinical decision rule - Implications for prescribing – J. Trubiano (AUSTRALIA)

  • Surveillance of serogroup B Neisseria meningitidis cases at United States colleges using the ProMED Mail platform – A. Srivastava, (USA)

  • Association of Cytomegalovirus Viremia with Pneumonia Severity in South African Children <5 Years of Age Enrolled in the PERCH Study – D. Moore (SOUTH AFRICA)

  • GeneXpert® Assay; and its Performance for the Diagnosis of HIV-associated Tuberculosis: Is Scale-Up worth It? – F. Rasheed (PAKISTAN)

Pediatric Infectious Diseases – Challenges and Opportunities

Room: HS 7M / Mezzanine

Sunday, September 13, 2020, 14:00 – 15:30 hrs

Co-chairs: C. Obiero (Kenya), T. Pinto (Brazil)
 

  • Optimizing Management of “Neonatal Sepsis” and our Path Towards Evidence-based Medicine – S. Saha (Bangladesh)

  • Re-emergence of Measles – TBD

  • Towards Eliminating HPV Associated Cancers: HPV Vaccination – Y.L Woo (Malaysia)

 

PLENARY

 

Plenary VI

Dengue

Room: EH 7A / Level 3

Sunday, September 13, 2020, 15:45 – 16:30 hrs

Chair: G. Malavige (Sri Lanka)
 

  • Innovations in Clinical Management of Dengue – B. Wills (Vietnam)

  • Dengue – Unusual Clinical Presentations – S. F. S. Omar (Malaysia)

  • ABUZZ: Citizen Science for Mosquito Monitoring – H. V. Narayanan (USA)